O'Mahony Denis, O'Sullivan David, Byrne Stephen, O'Connor Marie Noelle, Ryan Cristin, Gallagher Paul
Geriatric Medicine, University College Cork, Cork, Munster, Ireland Geriatric Medicine, Cork University Hospital, Cork, Munster, Ireland.
School of Pharmacy, University College Cork, Cork, Munster, Ireland.
Age Ageing. 2015 Mar;44(2):213-8. doi: 10.1093/ageing/afu145. Epub 2014 Oct 16.
Screening tool of older people's prescriptions (STOPP) and screening tool to alert to right treatment (START) criteria were first published in 2008. Due to an expanding therapeutics evidence base, updating of the criteria was required.
We reviewed the 2008 STOPP/START criteria to add new evidence-based criteria and remove any obsolete criteria. A thorough literature review was performed to reassess the evidence base of the 2008 criteria and the proposed new criteria. Nineteen experts from 13 European countries reviewed a new draft of STOPP & START criteria including proposed new criteria. These experts were also asked to propose additional criteria they considered important to include in the revised STOPP & START criteria and to highlight any criteria from the 2008 list they considered less important or lacking an evidence base. The revised list of criteria was then validated using the Delphi consensus methodology.
The expert panel agreed a final list of 114 criteria after two Delphi validation rounds, i.e. 80 STOPP criteria and 34 START criteria. This represents an overall 31% increase in STOPP/START criteria compared with version 1. Several new STOPP categories were created in version 2, namely antiplatelet/anticoagulant drugs, drugs affecting, or affected by, renal function and drugs that increase anticholinergic burden; new START categories include urogenital system drugs, analgesics and vaccines.
STOPP/START version 2 criteria have been expanded and updated for the purpose of minimizing inappropriate prescribing in older people. These criteria are based on an up-to-date literature review and consensus validation among a European panel of experts.
老年人处方筛查工具(STOPP)和正确治疗警示筛查工具(START)标准于2008年首次发布。由于治疗证据基础不断扩大,需要对这些标准进行更新。
我们对2008年的STOPP/START标准进行了审查,以添加新的循证标准并删除任何过时的标准。进行了全面的文献综述,以重新评估2008年标准和拟议的新标准的证据基础。来自13个欧洲国家的19位专家审查了STOPP和START标准的新草案,包括拟议的新标准。还要求这些专家提出他们认为应纳入修订后的STOPP和START标准的其他标准,并突出显示他们认为2008年列表中不太重要或缺乏证据基础的任何标准。然后使用德尔菲共识方法对修订后的标准列表进行验证。
经过两轮德尔菲验证,专家小组商定了一份最终的114条标准清单,即80条STOPP标准和34条START标准。与第1版相比,STOPP/START标准总体增加了31%。第2版中创建了几个新的STOPP类别,即抗血小板/抗凝药物、影响或受肾功能影响的药物以及增加抗胆碱能负担的药物;新的START类别包括泌尿生殖系统药物、镇痛药和疫苗。
STOPP/START第2版标准已经扩展和更新,目的是尽量减少老年人不适当的处方。这些标准基于最新的文献综述和欧洲专家小组的共识验证。